Listed here the top 15 Biotechnology Companies in India as of 2021 based on their market capital and net profit. India has established itself as a much sought after destination for biopharmaceutical companies with the biotechnology sector growing at a frenetic pace. We bring you the leading India based biotech companies who play a very significant role in India’s economic growth. The sector promises a high growth potential which has attracted numerous international players too.
The Indian biotech sector ranks as the 12th largest in the world with a 2% share of the global market. In Asia-Pacific, it comes in at number 3 right after Japan and China. By the end of 2025, the Indian biotech sector will cross the $100 billion mark as predicted by the Association of Biotechnology Led Enterprises.
India has a number of advantages working in its favor. It has a large pool of skilled personnel capable of carrying out innovative R&D. The Indian workforce in this sector also offers a cost-effective option for biotech multinationals looking to invest in the country. The Indian government is doing its bit by offering incentives, financial and otherwise at both the central and state levels.
The Indian biotech sector has been growing steadily with a number of mergers and acquisitions. Biotech companies in India have bagged lucrative and prestigious export orders by dint of their high-skilled labor and various low-cost advantages. We can divide the biotech sector in India into five categories.
- Biopharma: the use of proteins, drugs, and antibodies for diagnostics and therapeutic purposes
- Bioservices: companies entering into contracts related to manufacturing, research and clinical research with foreign clients
- Bio–IT: Bioinformatics related products and services
- Bioindustrial: this sector deals with yeast, organic amino acids, enzymes, and yeast-based products
- Bioagri: this sector deals with the production of biopesticides, genetically modified seeds, and biofertilizers
We now list the top 15 biotech companies in India. We give you some information about them in brief along with certain financial details of theirs.
Biocon
Biocon is headquartered in Bengaluru, Karnataka and it was founded in 1978. It largely exports its products to the American and European markets. It has two subsidiaries, one of them is Clinigene, a clinical research company and the other one is a custom research company Syngene. One of India’s leading biotechnology companies, Biocon is present in more than 70 countries.
- Market Capital- Rs. 47,106.00 crores
- P/E- 113.91
- Book Value- Rs. 62.80
- Face Value- Rs. 5.00
- Net Profit- Rs. 171.00 crores
Sun Pharma
Established in 1983 with five psychiatry products and a team of just two in the marketing division, Sun Pharma has had a phenomenal journey. It has a presence in as many as 24 countries. In 1997, Sun Pharma made its first international acquisition taking over Caraco Pharmaceutical Laboratories, USA. The company is actively involved in the R&D of biotechnology products.
- Market Capital- Rs. 5,015.59 crores
- P/E- NA
- Book Value- Rs. -0.71
- Face Value- Rs. 1.00
- Net Profit- Rs. 56.00 crores
Vivo Bio Tech
A full service CRO, Vivo Bio Tech offers its services for the purpose of drug discoveries and development to biotech and pharmaceutical companies across the globe. Its scientific team is involved in providing IND, regulatory and non-regulatory which enables preclinical development services. The company has capabilities in the screening and evaluation of molecules to gauge their pharmacological and therapeutic properties.
- Market Capital- Rs. 58.90 crores
- P/E- 13.25
- Book Value- Rs. 25.63
- Face Value- Rs. 10.00
- Net Profit- Rs. 00.00 crores
ANG Lifesciences India Limited
Set up in 2008 with the establishment of its manufacturing unit at Baddi in Himachal Pradesh, ANG LIfesciences is a fast growing company. It’s an injectables manufacturing unit equipped with state-of-the-art technology. It has very stringent quality control norms in place. The company has a skilled workforce involved actively in research and development.
- Market Capital- Rs. 22.55 crores
- P/E- NA
- Book Value- Rs. 66.67
- Face Value- Rs. 10.00
- Net Profit- NA
Wockhardt Limited
Workhardt has been contributing towards a healthier world by providing affordable medicines and biotechnology solutions. It’s a leading health enterprise with a robust R&D division and major investments in a chain of hospitals with word-class super-specialty hospitals. With 3 research centers and 12 manufacturing units, Wockhardt has a truly multi-ethnic workforce that’s 8,600 strong.
- Market Capital- Rs. 3,461.02 crores
- P/E- NA
- Book Value- Rs. 89.82
- Face Value- Rs. 5.00
- Net Profit- Rs. 68.00 crores
Piramal Enterprises Limited
A global conglomerate, Piramal Enterprises Limited comprises various companies working in several sectors. They had their beginnings in the textile sector and then diversified into healthcare, lifesciences, healthcare information management and more. The company has a well qualified and skilled workforce engaged in innovative research.
- Market Capital- Rs. 30,708.17 crores
- P/E- 145.97
- Book Value- Rs. 1003.29
- Face Value- Rs. 2.00
- Net Profit- Rs. 460.00 crores
GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline is one of the oldest pharmaceutical companies in India and was established in 1924. It’s a US$ 41.28 billion company that employs 4,500 people globally. They manufacture vaccines and prescription medicines. They lead the market in most of the therapeutic categories it operates in. It also offers many vaccines that help prevent serious diseases like Hepatitis B.
- Market Capital- Rs. 26,596.75 crores
- P/E- 247.36
- Book Value- Rs. 108.62
- Face Value- Rs. 10.00
- Net Profit- Rs. 110.00 crores
Panacea Biotec Limited
Panacea Biotec is a leading research-based health management company of India. It has innovative research and cutting edge manufacturing capabilities. It is strongly committed to spreading healthy living and good health. The company’s collaborations with both national and international research and commercial organizations give it access to the latest know-how in medical technology.
- Market Capital- Rs. 1,140.18 crores.
- P/E- NA
- Book Value- Rs. 145.75
- Face Value- Rs. 1.00
- Net Profit- Rs. -69.00 crores
AstraZeneca Pharma Limited
A subsidiary of the British company, AstraZeneca Plc, UK, AstraZeneca Pharma Ltd. was set up in India in 1979 with its headquarters being in Bengaluru, Karnataka. With a dedicated team of 1400 professionals, the company’s mission is to provide critical medicines to people through innovation and achieve global excellence.
- Market Capital- Rs. 8,891.62 crores.
- P/E- 128.01
- Book Value- Rs. 145.78
- Face Value- Rs. 2.00
- Net Profit- Rs. 18.00 crores
Lupin Limited
Lupin commenced on its path of steady growth in the year 1968. The visionary, Dr. Desh Bandhu Gupta was its founder. Lupin finds its name from the flower of the same name that’s known to nourish the soil it grows on. The company’s mission is to provide affordable high-quality drugs that help save lives and nourish the good health of Indians and people around the globe.
- Market Capital- Rs. 42,041.37 crores.
- P/E- 65.2
- Book Value- Rs. 385.59
- Face Value- Rs. 20.00
- Net Profit- Rs. 108.00 crores
Cadila Healthcare Limited
Cadila was founded by Ramabhai Patel in 1952. Ever since then, there’s been no looking back. The company has grown from strength to strength and has established itself as one of India’s largest private pharmaceutical companies. Over the last six decades, Cadila has made life saving drugs affordable for millions across the globe. They have invested heavily in innovation and R&D.
- Market Capital- Rs. 38,021.80 crores.
- P/E- 20.44
- Book Value- Rs. 109.99
- Face Value- Rs. 1.00
- Net Profit- Rs. 469.00 crores
Cipla Limited
Cipla was founded by Khwaja Abdul Hamied in the year 1953. Headquartered in Mumbai, the company has established itself as one of India’s most reputed pharmaceutical companies. Most of its medicines help prevent cardiovascular and respiratory ailments as well as diabetes and arthtritis. Its inhalers for patients of asthma are very popular in India.
- Market Capital- Rs. 57,419.00 crores.
- P/E- 25.75
- Book Value- Rs. 215.83
- Face Value- Rs. 2.00
- Net Profit- Rs. 571.00 crores
Novartis India Limited
Novartis is a company with its roots in Switzerland and it has a major presence in India. The company was created in 1966 when Ciba-Geigy and Sandoz were merged. In India, Novartis has its registered office in Mumbai, Maharashtra. With path-breaking research and development, Novartis has brought many innovative medicines that have been a boon to many patients.
- Market Capital- Rs. 1,534.16 crores.
- P/E- 112.16
- Book Value- Rs. 291.90
- Face Value- Rs. 5.00
- Net Profit- Rs. 4.00 crores
Krebs Biochemicals & Industries Limited
Headquartered in Hyderabad, Telengana, Krebs was founded in 1991. It’s engaged in discovering biotech processes that can be applied in medicines and are commercially viable. It has two state-of-the-art manufacturing plants in Nellore and Vizag, both in Andhra Pradesh. KBIL specializes in the areas of fermentation, enzymatic technologies and fermentation.
- Market Capital- Rs. 164.92 crores
- P/E- NA
- Book Value- Rs. -11.91
- Face Value- Rs. 10.00
- Net Profit- Rs. -6.00 crores
Syngene International Limited
Syngene International Limited is another of India’s leading biotechnology firms and it has its headquarters in Bengaluru, Karnataka. It is involved in research and development of clinical supplies. They possess expertise in integrated drug discovery and development. They are involved in toxicology, biology, medicinal chemistry, vivo pharmacology, custom synthesis among others.
- Market Capital- Rs. 18,920.00 crores.
- P/E- 47.71
- Book Value- Rs. 54.35
- Face Value- Rs. 10.00
- Net Profit- Rs. 58.00 crores
Conclusion
Our article brings you the top 15 biotech companies in India that have a major presence in the market. Most of these companies have successfully established themselves as leaders not just in India, but globally too. Through R&D, they have made medicines affordable for millions earning immense goodwill.